Entry into a Material Definitive Agreement. Agreement and Plan of Merger On July 29, 2026, MiMedx Group, Inc., a Florida corporation ( “ MiMedx ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Sanara MedTech Inc., a Texas corporation (“ Sanara ”), and Mustang Merger Sub, Inc., a wholly-owned subsidiary of MiMedx (“ Merger Subsidiary ”), pursuant to which, among other things and subject to the terms and conditions of the Merger Agreement, Merger Subsidiary will…

of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 shall not be deemed to be incorporated by reference into the filings of MiMedx under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of the federal…

of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 shall not be deemed to be incorporated by reference into the filings of MiMedx under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of the federal…

Results of Operations and Financial Condition On July 29, 2026, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the second quarter of 2026. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not be dee…

Entry into a Material Definitive Agreement. Agreement and Plan of Merger On July 29, 2026, MiMedx Group, Inc., a Florida corporation ( “ MiMedx ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Sanara MedTech Inc., a Texas corporation (“ Sanara ”), and Mustang Merger Sub, Inc., a wholly-owned subsidiary of MiMedx (“ Merger Subsidiary ”), pursuant to which, among other things and subject to the terms and conditions of the Merger Agreement, Merger Subsidiary will…

Results of Operations and Financial Condition On April 29, 2026, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the first quarter of 2026. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not be dee…

Chief Operating Officer — Ricci Whitlow: Position eliminated as part of a cost reduction initiative.

Results of Operations and Financial Condition On February 25, 2026, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the fourth quarter and full year ended December 31, 2025. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 att…

Results of Operations and Financial Condition. On October 29, 2025 , MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the quarter that ended September 30, 2025. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto,…

Results of Operations and Financial Condition. On July 30, 2025 , MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the quarter ended June 30, 2025. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not…

Results of Operations and Financial Condition. On April 30, 2025, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the quarter ended March 31, 2025. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall no…

Results of Operations and Financial Condition. On February 26, 2025, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the fourth quarter and full year ended December 31, 2024. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 at…

Entry into a Material Agreement On December 11, 2024, the Board of Directors of MiMedx Group, Inc. (the “ Company ”) approved a form of Indemnification Agreement to be entered into by the Company with each of its directors and executive officers (as defined by, and determined in accordance with, Section 16 and Rule 3b-7 of the Securities Exchange Act of 1934) (each, an “ Indemnitee ”) and authorized the Company to enter into separate Indemnification Agreements (the “ Agreements ”) with each I…

Results of Operations and Financial Condition. On October 30, 2024, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the third quarter ended September 30, 2024. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto,…

Results of Operations and Financial Condition. On July 31, 2024, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the second quarter ended June 30, 2024. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and sha…

Results of Operations and Financial Condition. On April 30, 2024, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the first quarter ended March 31, 2024. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and sh…

Director — Ms. Tiffany P. Olson and Ms. Dorothy E. Puhy: The Board approved an increase in its size and appointed two new directors.

Results of Operations and Financial Condition. On February 28, 2024, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the fourth quarter and full year ended December 31, 2023. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 at…

Termination of a Material Definitive Agreement. With respect to the termination of the Hayfin Credit Agreement, the information set forth above in

Entry into a Material Definitive Agreement. On January 19, 2024, MiMedx Group, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with the lenders party thereto (the “Lenders”) and Citizens Bank, N.A., as administrative agent (the “Agent”). All obligations of the Company under the Credit Agreement are guaranteed by certain of the Company’s subsidiaries (collectively, the “Guarantors”) and secured by substantially all of the assets of the Company and the Guarantors p…

Regulation FD Disclosure. On January 22, 2024, the Company issued a press release regarding the entry into the Credit Agreement. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. With respect to the Credit Agreement, the information set forth above in

Results of Operations and Financial Condition. On October 30, 2023, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the third quarter ended September 30, 2023. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto,…

Chief Accounting Officer — William Phelan: Mr. Phelan decided to retire following the combination of CFO and Chief Accounting Officer roles into a single position assumed by Mr. Rice.

Results of Operations and Financial Condition. On August 1, 2023, MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the second quarter ended June 30, 2023. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and sh…